Fjarde AP Fonden Fourth Swedish National Pension Fund trimmed its position in Danaher Corporation (NYSE:DHR – Free Report) by 5.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,372 shares of the conglomerate’s stock after selling 5,800 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Danaher were worth $23,664,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Capital International Investors increased its holdings in Danaher by 1.9% during the 3rd quarter. Capital International Investors now owns 16,758,240 shares of the conglomerate’s stock worth $3,318,926,000 after purchasing an additional 312,951 shares in the last quarter. Norges Bank bought a new stake in Danaher during the 4th quarter worth approximately $2,177,106,000. Generation Investment Management LLP increased its holdings in Danaher by 34.0% during the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after purchasing an additional 1,689,020 shares in the last quarter. Legal & General Group Plc increased its holdings in Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after purchasing an additional 43,169 shares in the last quarter. Finally, Fisher Asset Management LLC increased its holdings in Danaher by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,446,976 shares of the conglomerate’s stock worth $1,018,002,000 after purchasing an additional 77,757 shares in the last quarter. 79.05% of the stock is owned by institutional investors.
Danaher Price Performance
Shares of NYSE DHR opened at $184.45 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock’s 50 day moving average price is $181.29 and its 200-day moving average price is $206.19. The company has a market capitalization of $130.55 billion, a PE ratio of 35.68, a PEG ratio of 2.49 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.
Analyst Upgrades and Downgrades
DHR has been the subject of a number of recent research reports. Royal Bank Of Canada initiated coverage on Danaher in a report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price objective for the company. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a report on Friday, April 17th. Finally, The Goldman Sachs Group decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $235.14.
Check Out Our Latest Research Report on DHR
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
